Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 4/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 4/20 | 0.38 |
| ▸ | GRIA3 | P42263 | 4/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 4/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.37 |
| ▸ | LARS1 | Q9P2J5 | 2/20 | 0.36 |
| ▸ | ALPI | P09923 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | XIAP | P98170 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL1537416 | 1.00 | SLC7A5 (0.51) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL716108 | 1.00 | SLC7A5 (0.51) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL28870433 | 0.99 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL5072093 | 0.97 | SLC7A5 (0.49) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL21925063 | 0.97 | SLC7A5 (0.49) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL21774926 | 0.95 | SLC7A5 (0.46) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL26967573 | 0.95 | SLC7A5 (0.46) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL21638967 | 0.94 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Histidine SCHEMBL245022 | 0.94 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2CYP3A4CYP1A2 | |
| Phenylalanine SCHEMBL14631617 | 0.91 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023225619-A2 | DELIVERY OF FOCAL ADHESION KINASE FOR TREATING VASCULAR AND/OR CAPILLARY TISSUE INJURY | BIOSUPERIOR TECHNOLOGY, INC. (US) | 2023-11-23 | — | — | WO | claimed |
| US-20100286023-A1 | Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly | ENERGY LIGHT LLC | 2010-11-11 | — | — | US | claimed |
| US-7790688-B2 | Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly | HEALTHSPAN SOLUTIONS, LLC (US) | 2010-09-07 | — | — | US | claimed |
| WO-2023225619-A2 | DELIVERY OF FOCAL ADHESION KINASE FOR TREATING VASCULAR AND/OR CAPILLARY TISSUE INJURY | BIOSUPERIOR TECHNOLOGY, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-114989250-B | Angiotensin converting enzyme inhibitory polypeptide from seawater pearl and application thereof | 浙江清荣生物科技发展有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-115176952-A | Preparation method of agrocybe cylindracea fermented radix puerariae and coix seed beverage | 贵州大学 | 2022-10-14 | — | — | CN | disclosed |
| CN-114752525-B | Lactobacillus casei with blood pressure lowering effect and application thereof | 广西壮族自治区水牛研究所 | 2022-09-09 | — | — | CN | disclosed |
| CN-114989250-A | Angiotensin converting enzyme inhibitory polypeptide derived from seawater pearl and application thereof | 浙江清荣生物科技发展有限公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-114752525-A | Lactobacillus casei with blood pressure lowering effect and application thereof | 广西壮族自治区水牛研究所 | 2022-07-15 | — | — | CN | disclosed |
| CN-109942447-A | A kind of amino acid-extraction | 罗江晨明生物制品有限公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-108271372-A | IL-8-BINDING ANTIBODIES AND USES THEREOF | 中外制药株式会社 | 2018-07-10 | — | — | CN | disclosed |
| CN-101171024-A | Blood pressure lowering protein hydrolysates | DSM IP ASSETS BV (NL) | 2008-04-30 | — | — | CN | disclosed |
| US-20070128192-A1 | Human antibody molecules for il-13 | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 2007-06-07 | — | — | US | disclosed |
| CN-1893838-A | Peptides having an ace inhibiting effect | UNILEVER NV (NL) | 2007-01-10 | — | — | CN | disclosed |
| EP-1646656-A2 | HUMAN ANTIBODY MOLECULES FOR IL-13 | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 2006-04-19 | — | — | EP | disclosed |
| US-6905818-B1 | Method for the identification and characterization of interacting molecules by automated interaction mating | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNGDER WISSENSCHAFTEN (DE) | 2005-06-14 | — | — | US | disclosed |
| US-20050065327-A1 | Human antibody molecules for IL-13 | MEDIMMUNE LIMITED (GB) | 2005-03-24 | — | — | US | disclosed |
| WO-2005007699-A2 | HUMAN ANTIBODY MOLECULES FOR IL-13 | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 2005-01-27 | — | — | WO | disclosed |
| WO-1997039132-A9 | STABILIZED PREPARATIONS OF HUMAN TROPONINS AND MODIFICATIONS THEREOF, DIAGNOSTIC ASSAY METHODS AND ASSAY KITS | — | 1997-12-24 | — | — | WO | disclosed |
| WO-1997039132-A1 | STABILIZED PREPARATIONS OF HUMAN TROPONINS AND MODIFICATIONS THEREOF, DIAGNOSTIC ASSAY METHODS AND ASSAY KITS | UNIVERSITY OF MIAMI (US) | 1997-10-23 | — | — | WO | disclosed |